| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/15/2004 | EP1150918B1 Method of manufacturing therapeutic calcium phosphate particles |
| 09/15/2004 | EP1140077B1 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 09/15/2004 | EP1123111B1 Modulation of dna methyltransferase expression by combination therapy |
| 09/15/2004 | EP1032708A4 Nucleic acid ligands of tissue target |
| 09/15/2004 | EP1023319B1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 09/15/2004 | EP1015482A4 Isolated candida albicans oligopeptide transporter gene |
| 09/15/2004 | EP1015010A4 Prevention of pregnancy miscarriages |
| 09/15/2004 | EP1007095B1 CHIMERIC TOXINS COMPRISING GnRH FOR TARGETED THERAPY |
| 09/15/2004 | EP1001814B1 Controlled release microencapsulated ngf formulation |
| 09/15/2004 | EP1001806B1 Cellular vesicle called ''exosome'', preparation and use thereof in immune stimulation |
| 09/15/2004 | EP0988046B1 Oil-free pharmaceutical compositions containing cyclosporin a |
| 09/15/2004 | EP0981282B1 Process for preparing a nutritional supplement and nutritional supplement |
| 09/15/2004 | EP0970106B1 uPAR-MIMICKING PEPTIDES |
| 09/15/2004 | EP0938326B1 Synthetic phosphopeptides for treating bone diseases |
| 09/15/2004 | EP0877760B1 Mhc complexes and uses thereof |
| 09/15/2004 | EP0871468B1 Treatment of prostate cancer with lhrh antagonists |
| 09/15/2004 | EP0859601B1 Prolonged release of gm-csf |
| 09/15/2004 | EP0855916B1 Pharmaceutical composition containing an activin stimulator |
| 09/15/2004 | EP0841939B1 Therapeutic agents and autoimmune diseases |
| 09/15/2004 | EP0841937B1 Use of betaglycan to reduce scarring |
| 09/15/2004 | EP0837881B1 CONJUGATES OF alpha-MSH WITH A FATTY ACID, PREPARATION METHOD THEREFOR, AND USE THEREOF AS A DRUG |
| 09/15/2004 | EP0783579B1 Antigenic fragment of the tagA gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma |
| 09/15/2004 | EP0733104B1 Purification of vitamin-k dependent proteins by membrane chromatography |
| 09/15/2004 | EP0714404B1 Anti-inflammatory peptides |
| 09/15/2004 | EP0707644B1 Use of pharmaceutical compositions for the treatment of neurodegenerative diseases |
| 09/15/2004 | EP0678523B1 Recombinant anti-hiv antibody and preparation thereof |
| 09/15/2004 | EP0671910B1 Use of adamantane derivatives for the manufacture of a medicament in the TREATMENT of glaucoma |
| 09/15/2004 | EP0656786B1 Use of isoflavone phyto-oestrogen extracts of soy or clover |
| 09/15/2004 | EP0647275B1 Cloning and expression of gonadotropin-releasing hormone receptor |
| 09/15/2004 | EP0624195B1 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides |
| 09/15/2004 | CN1529757A Fusion Protein for secretion of protein of interest in supernatant of bacterial culture |
| 09/15/2004 | CN1529753A Disease-associated protein |
| 09/15/2004 | CN1529751A Method for purifying enzyme, purified enzyme produced thereby and use of this enzyme |
| 09/15/2004 | CN1529714A Modified interfron alpha with reduced immunogenicity |
| 09/15/2004 | CN1529713A Compositions and methods for therapy and diagnosis of ovarian cancer |
| 09/15/2004 | CN1529619A Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enbancing agents |
| 09/15/2004 | CN1529618A Induction of tolerance |
| 09/15/2004 | CN1529617A Method for treaing autoimmune diseases in subject and in vitro diagnostic assays |
| 09/15/2004 | CN1529614A Method of reducing side effects of chemotherapy in cancer patient |
| 09/15/2004 | CN1529613A Method for using nervous thread proteins to treat tumors and other conditions requiring removal of destruction of cells |
| 09/15/2004 | CN1529612A Targeted delivery of drugs for treatment of viral infections |
| 09/15/2004 | CN1529611A Use of IL-18 inhibitors for treatment or prevention of sepsis |
| 09/15/2004 | CN1529607A Treatment of T cell disorders |
| 09/15/2004 | CN1529604A Drug for treatment of osteonecrosis and for management of patients at risk of evelopment osteonecrosis |
| 09/15/2004 | CN1528790A Unsaturated fatty acid modified insulin and preparing method thereof |
| 09/15/2004 | CN1528789A Alpha-lipoic acid and its derivative modified insulin and preparing method thereof |
| 09/15/2004 | CN1528788A Cholalic acid derivative medified insulin and preparing method thereof |
| 09/15/2004 | CN1528783A Bursopoietin extracting method and its use in disease treating and immune |
| 09/15/2004 | CN1528451A Novel use of serum beta 2-glucoprotein I functional peptide segment for preparing thrombolytic medicine |
| 09/15/2004 | CN1528450A Use of serum beta 2-glucoprotein I functional peptide segment for preparing thrombolytic medicine |
| 09/15/2004 | CN1528313A Complex external medicine for treating psoriasis |
| 09/15/2004 | CN1528196A Broad-spectrum antibiotic antivirus complex chinese-western medicine-food dual-purpose nutrient for preventing and treating pharyngitis and preparing method thereof |
| 09/15/2004 | CN1528150A Biological agent for foot disinfection |
| 09/15/2004 | CN1528138A Foot disinfectant |
| 09/15/2004 | CN1166773C Differentiation of adipose stromal cells into osteobalsts |
| 09/15/2004 | CN1166772C Process for controlling sialylation of protein produced by mammalian cell culture |
| 09/15/2004 | CN1166690C Hepatitis C inhibitor peptides |
| 09/15/2004 | CN1166687C Medicine combined by moleculae of growth factor and traumatic factor in gall |
| 09/15/2004 | CN1166686C New human protein with the function of inhibiting cancer cell growth and its coding sequence |
| 09/15/2004 | CN1166683C New BPC peptide salts with organo-protective activity, the process for their preparation and their use in therapy |
| 09/15/2004 | CN1166682C Bacteriocidal/permeation enhanced protein functional area bioactive pipetide |
| 09/15/2004 | CN1166633C New alpha-amino acid sulfuryl compounds, its preparing method and medicinal composition containing them |
| 09/15/2004 | CN1166631C S-nitrosothiols as agents for the treatment of circulatory dysfunctions |
| 09/15/2004 | CN1166597C Nitrogenous group conversion method |
| 09/15/2004 | CN1166414C Method for preparing degradable biologically active artificial bone |
| 09/15/2004 | CN1166409C Use of melanoma differentiation associated gene (mda 7) for reversing cancerous phenotype |
| 09/15/2004 | CN1166407C Application of agrose in preparing medicine for prostate hyperplosia |
| 09/15/2004 | CN1166406C Composition and pharmaceutical dosage form for colonic drug delivery using polysaccharides |
| 09/15/2004 | CN1166405C Antiviral agent in form of nose drops |
| 09/15/2004 | CN1166404C Midicine for resisting tuberculosis and preparation method |
| 09/15/2004 | CN1166403C Multicatalytic protease inhibitors |
| 09/15/2004 | CN1166361C Use of CGRP antagonists and CGRP release inhibitors for controlling menopausal hot flashes |
| 09/14/2004 | US6790989 Interleukin-1 beta converting enzyme/caspase; for prolonging viability of organs/cells for transplantation; for treating inflammatory, autoimmnune and neurodegenerative diseases; prevention of ischemic injury |
| 09/14/2004 | US6790947 Polynucleotides encoding macrophage derived chemokine |
| 09/14/2004 | US6790941 Zinc finger protein derivatives and methods therefor |
| 09/14/2004 | US6790939 Anti-PSCA antibodies |
| 09/14/2004 | US6790938 Human autoantibodies and antiidiotypic antibodies against blood platelet membrane proteins |
| 09/14/2004 | US6790864 Nonsteroidal antiinflammatory drugs which have been substituted with a nitrogen monoxide group; compositions comprising (i) a nonsteroidal antiinflammatory drug, which can optionally be substituted with a nitrogen monoxide group |
| 09/14/2004 | US6790855 Two compounds, one effecting opioid analgesia and one effecting local anesthesia, in amounts sufficient to potentiate an antinociceptive response when both compounds are topically administered |
| 09/14/2004 | US6790838 Gene therapy; administering mixture of triiodotyronine and flbroblast growth factor |
| 09/14/2004 | US6790833 Oligopeptides obtained from the mucd1 domain of the saliva mucin glycoprotein muc7 have a net positive charge |
| 09/14/2004 | US6790832 Antithrombin; antiinflammatory agents, rheumatic diseases |
| 09/14/2004 | US6790831 For use in testing systemic carnitine deficiency |
| 09/14/2004 | US6790830 Use of 3-position cyclosporin derivatives for hair growth |
| 09/14/2004 | US6790829 Cyclic decapeptide antibiotics |
| 09/14/2004 | US6790828 Glycoprotein mimetics having ability for potentiation of thrombin-mediated activation of protein c and inability to activate thrombin-activatable fibrinolysis inhibitor (tafi), used as anticoagulants |
| 09/14/2004 | US6790827 Bioconjugates and delivery of bioactive agents |
| 09/14/2004 | US6790826 Human haemopoietic maturation factor |
| 09/14/2004 | US6790825 Stimulating secretion of pancreatic juices |
| 09/14/2004 | US6790824 Cytokines having neurotrophic activity |
| 09/14/2004 | US6790823 Compositions and methods for the prevention and treatment of cardiovascular diseases |
| 09/14/2004 | US6790658 Nucleotide sequences coding polypeptide for use in the treatment and prevention of wounds, angiogenesis, restenosis, atherosclerosis, inflammation, nervous system disorders and cancer |
| 09/14/2004 | US6790656 Galanin receptors (galr2); involved in various neurological and neurodegenerative disorders and treatments |
| 09/14/2004 | US6790649 Phex gene (phosphate regulating gene with homologies to endopeptidases on x chromosome); for treatment of x-linked hypophosphatemia (xlh), a phosphate homeostasis disorder; retardation, bone, renal and metabolism disorders |
| 09/14/2004 | US6790639 Bone morphogenic proteins; for regulating bone homeostasis, adiposity, and calcification of atherosclerotic plaques |
| 09/14/2004 | US6790637 Mammalian gene, BCL-W, belongs to the BCL-2 family of apoptosis-controlling genes |
| 09/14/2004 | US6790633 Prevents binding of ras protein in malignant cells |
| 09/14/2004 | US6790631 For diagnosis and therapy of prostate cancer; qualitative analysis |
| 09/14/2004 | US6790629 Receptor polypeptide for use in the treatment and diagnosis of painful syndromes |
| 09/14/2004 | US6790628 Screening granulocyte colony stimulating factor(g-csf) poly-peptide analogs to use as g-csf replacements or antagonists; sensitizing cells to chemo/radiotherapy; treating hemato-poietic, neurological or reproduction related conditions |